Get the Stockscreener App
20.04
1.78%
0.35
After Hours:
19.89
-0.15
-0.75%
Novocure Ltd Stock (NVCR) Latest News
NovoCure Ltd’s (NVCR) 10.12% Increase Justifies A Second Look - Stocks Register
Novocure to Participate in Upcoming Investor Conferences - Yahoo Finance
NVCR (NovoCure) Shares Outstanding (EOP) : 108.1 Mil (As of Sep. 2024) - GuruFocus.com
Novocure's SWOT analysis: FDA approval boosts cancer tech stock prospects - Investing.com
NovoCure (NASDAQ:NVCR) Receives Buy Rating from HC Wainwright - Defense World
NVCR (NovoCure) Growth Rank : 8 (As of Nov. 24, 2024) - GuruFocus.com
Connor Clark & Lunn Investment Management Ltd. Acquires 59,608 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat
FDA approves Novocure's new device for brain cancer treatment By Investing.com - Investing.com Nigeria
Novocure secures FDA approval for add-ons to brain cancer treatment wearable - Yahoo Finance
Novocure’s HFE Transducer Arrays OK’ed with Optune Gio for Glioblastoma - MPO-mag
FDA approves Novocure's new device for brain cancer treatment - Investing.com
Novocure to Present Breakthrough TTFields Brain Cancer Treatment Data at SNO Meeting | NVCR Stock News - StockTitan
FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma - Yahoo Finance
Can Novocure's PANOVA-3 Trial Of TTFields Therapy Electrify The Stock? - RTTNews
NovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
NovoCure (NVCR) Shares Cross Below 200 DMA - Nasdaq
NovoCure Ltd (NVCR) Trading Down 2.79% on Nov 14 - GuruFocus.com
Baillie Gifford & Co. Sells 28,207 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat
Analyze NovoCure Ltd (NASDAQ: NVCR) Before Investing. - Stocks Register
Nordwand Advisors LLC Buys 1,514,824 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat
NovoCure Ltd (NVCR) Shares Up 3.63% on Nov 8 - GuruFocus.com
Novocure's oncology president sells $9,530 in shares - Investing.com India
Novocure's COO Mukund sells shares worth $2,540 By Investing.com - Investing.com Canada
Novocure's COO Mukund sells shares worth $2,540 - Investing.com India
Michal Nath Puri Sells 810 Shares of NovoCure Limited (NASDAQ:NVCR) Stock - MarketBeat
Novocure's oncology president sells $9,530 in shares By Investing.com - Investing.com Australia
NovoCure Ltd (NVCR) Shares Up 3.96% on Nov 4 - GuruFocus.com
FY2024 EPS Estimates for NovoCure Lifted by HC Wainwright - MarketBeat
Analyst Estimates: Here's What Brokers Think Of NovoCure Limited (NASDAQ:NVCR) After Its Third-Quarter Report - Simply Wall St
NovoCure Limited (NASDAQ:NVCR) Q3 2024 Earnings Call Transcript - Insider Monkey
NovoCure shares hold Buy rating, steady price target post-earnings - Investing.com
NovoCure shares hold Buy rating, steady price target post-earnings By Investing.com - Investing.com UK
NovoCure's (NVCR) Buy Rating Reiterated at HC Wainwright - MarketBeat
NovoCure’s Strong Q3 and Leadership Changes in 2024 - Yahoo Finance
NovoCure: Q3 Earnings Snapshot - Milford Mirror
NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
Novocure names Christoph Brackmann as new CFO - Investing.com India
Novocure’s Q3 2024 Results Highlight Growth and Innovation - TipRanks
NovoCure (NASDAQ:NVCR) Stock Price Down 7.1%Should You Sell? - MarketBeat
Novocure Ltd earnings beat by $0.05, revenue topped estimates - Investing.com
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Novocure Appoints Christoph Brackmann as Chief Financial Officer - Yahoo Finance
Novocure Reports Third Quarter 2024 Financial Results - Yahoo Finance
Semanteon Capital Management LP Makes New Investment in NovoCure Limited (NASDAQ:NVCR) - MarketBeat
NovoCure (NVCR) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Brokerages Set NovoCure Limited (NASDAQ:NVCR) PT at $26.17 - MarketBeat
NovoCure Limited (NASDAQ:NVCR) Shares Sold by SG Americas Securities LLC - MarketBeat
0.73%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):